A*STAR和旗舰先锋宣布建立合作伙伴关系，以促进新加坡的生物技术创新

Organizations Plan to Jointly Advance Breakthrough Solutions in Human Health and Sustainability, Drive Research Collaboration, Entrepreneurship and Accelerate Talent DevelopmentSINGAPORE, Oct. 2, 2024 /PRNewswire/ -- The Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, and Flagship Pioneering, the bioplatform innovation company, today announced plans to collaborate to advance health and sustainability outcomes in Singapore and the broader Asia Pacific region.

各组织计划共同推进人类健康和可持续发展方面的突破性解决方案，推动研究合作、创业和加速人才发展新加坡，2024年10月2日/PRNewswire/--新加坡领先的公共部门研发机构科学技术研究机构（A*STAR）和旗舰先锋生物平台创新公司今天宣布计划合作，以促进新加坡和更广泛的亚太地区的健康和可持续发展成果。

In this collaboration, A*STAR and Flagship will jointly commit up to SGD100 million over the next five years..

在这次合作中，A*STAR和Flagship将在未来五年共同承诺高达1亿新元。。

A*STAR and Flagship team members sign Memorandum of Understanding.

明星和旗舰团队成员签署谅解备忘录。

A*STAR and Flagship outlined the goals of their collaboration via a Memorandum of Understanding (MOU) signed Tuesday. The collaboration will promote research and development activities between A*STAR research institutes and Flagship portfolio companies, to co-develop technologies in strategically important areas.

。此次合作将促进明星研究机构和旗舰投资组合公司之间的研发活动，共同开发战略重要领域的技术。

Talent development is another pillar of the collaboration, with potential scientific dialogues and internship opportunities at Flagship and its portfolio companies..

。。

Together, A*STAR and Flagship seek to spur innovation and venture creation activities that help create and grow Flagship companies in Singapore. Flagship will contribute its signature approach to company creation and development while A*STAR will contribute its expertise in science and technology through access to its scientists and facilities.

A*STAR和Flagship共同寻求刺激创新和创业活动，帮助新加坡创建和发展旗舰公司。旗舰将为公司的创建和发展贡献其标志性的方法，而A*STAR将通过访问其科学家和设施来贡献其在科学和技术方面的专业知识。

This MOU will have the potential to expand and foster collaborations among key players across Singapore's biotech ecosystem..

这份谅解备忘录将有可能扩大和促进新加坡生物技术生态系统关键参与者之间的合作。。

'By joining forces, Flagship and A*STAR can further boost the already thriving life sciences ecosystem in Singapore and beyond, with breakthrough research, purposeful entrepreneurship and accelerated talent development,' said André Andonian, Chair of Asia Pacific and Strategic Advisor, Flagship Pioneering.

亚太区主席兼旗舰创业公司战略顾问安德烈·安多尼亚（AndréAndonian）说：“旗舰公司和A*STAR联合起来，可以通过突破性研究、有目的的创业精神和加速人才发展，进一步推动新加坡及其他地区已经蓬勃发展的生命科学生态系统。”。

'This collaboration blends scientific acumen and entrepreneurial spirit and will further accelerate and expand Flagship's impact globally. We are pleased to announce this collaboration with A*STAR within the first year of opening our new Asia Pacific hub, located in Singapore.''We are excited to be working with globally-recognized venture builders like Flagship Pioneering, to bring new companies with cutting-edge technologies in areas of strategic interest to Singapore,' said Irene Cheong, Assistant Chief Executive at A*STAR's Innovation & Enterprise Group.

“此次合作融合了科学敏锐和创业精神，将进一步加速和扩大旗舰在全球的影响力。我们很高兴宣布，在我们位于新加坡的新亚太中心开业的第一年内，我们将与A*STAR进行合作A*STAR创新与企业集团（A*STAR’s Innovation&Enterprise Group）助理首席执行官张爱玲（Irene Cheong）表示，我们很高兴能与旗舰创业（Flagship Exponental）等全球公认的风险投资机构合作，为新加坡带来在战略利益领域拥有尖端技术的新公司。

'This collaboration is a key step in nurturing our entrepreneurial talent and exploring new, innovative approaches to venture building. As we continue to expand these partnerships, we are confident that they will drive significant growth in Singapore's innovation landscape and advance Singapore's position as a global hub for biotechnological innovations.'About the Agency for Science, Technology and Research (A*STAR)The Agency for Science, Technology and Research (A*STAR) is Singapore's lead public sector R&D agency.

“这种合作是培养我们创业人才和探索新的创新创业方法的关键一步。随着我们继续扩大这些伙伴关系，我们相信它们将推动新加坡创新格局的显着增长，并提升新加坡作为全球生物技术创新中心的地位。”关于科学、技术和研究机构（A*STAR）科学、技术和研究机构（A*STAR）是新加坡领先的公共部门研发机构。

Through open innovation, we collaborate with our partners in both the public and private sectors to benefit the economy and society. As a Science and Technology Organisation, A*STAR bridges the gap between academia and industry. Our research creates economic growth and jobs for Singapore, and enhances lives by improving societal outcomes in healthcare, urban living, and sustainability.

通过开放式创新，我们与公共和私营部门的合作伙伴合作，造福于经济和社会。作为一个科学技术组织，a*星架起了学术界和工业界之间的桥梁。我们的研究为新加坡创造了经济增长和就业机会，并通过改善医疗保健、城市生活和可持续性方面的社会成果来改善生活。

A*STAR plays a ke.

一个明星扮演一个ke。

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

想在PRNEWSWIRE上发布贵公司的新闻。COM？

网址：A*STAR和旗舰先锋宣布建立合作伙伴关系，以促进新加坡的生物技术创新 http://mxgxt.com/news/view/910599

相关内容

Ring Therapeutics与A*STAR和SERI建立合作伙伴关系，以促进新加坡的基因治疗研究
传音 TECNO 全球旗舰新品发布会 2023——以先锋科技诠释时尚设计
布加迪汽车公司与嘉信集团建立合作伙伴关系
机器人创新生态明星合作伙伴
如何建立有效的合作伙伴关系 – PingCode
程序员问答平台 Stack Overflow 宣布与 OpenAI 建立合作伙伴关系
新壹科技受邀参加2024创新产业链合作促进大会
合作伙伴关系：麦肯锡如何与客户和合作伙伴建立良好的合作关系？
高通与产业伙伴合作，推动5G标准相关技术在更多行业的落地应用
利物浦足球俱乐部在韩国建立首个官方零售合作伙伴关系 继续国际增长

随便看看